A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT06879041 · RECRUITING

Trial details

NCT number: NCT06879041
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Cancer

Start date: 2025-03-10
Primary completion: 2029-04-16
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.